Turpie AGG - Search Results

1

Influence of body mass index on clinical outcomes in venous thromboembolism: Insights from GARFIELD-VTE.

Weitz JI, Farjat AE, Ageno W, Turpie AGG, Haas S, Goto S, Goldhaber SZ, Angchaisuksiri P, Gibbs H, MacCallum P, Carrier M, Kayani G, Schellong S, Bounameaux H, Mantovani LG, Prandoni P, Kakkar AK; GARFIELD-VTE Investigators. Weitz JI, et al. Among authors: turpie agg. J Thromb Haemost. 2021 Dec;19(12):3031-3043. doi: 10.1111/jth.15520. Epub 2021 Sep 16. J Thromb Haemost. 2021. PMID: 34487616 Free article.

2

New advances in the management of acute coronary syndromes: 4. Low-molecular-weight heparins.

Ageno W, Turpie AG. Ageno W, et al. CMAJ. 2002 Apr 2;166(7):919-24. CMAJ. 2002. PMID: 11949991 Free PMC article. Review. No abstract available.

3

Review of enoxaparin and its clinical applications in venous and arterial thromboembolism.

Turpie AG, Mason JA. Turpie AG, et al. Expert Opin Pharmacother. 2002 May;3(5):575-98. doi: 10.1517/14656566.3.5.575. Expert Opin Pharmacother. 2002. PMID: 11996636 Review.

4

ABC of antithrombotic therapy: Venous thromboembolism: treatment strategies.

Turpie AG, Chin BS, Lip GY. Turpie AG, et al. BMJ. 2002 Oct 26;325(7370):948-50. doi: 10.1136/bmj.325.7370.948. BMJ. 2002. PMID: 12399348 Free PMC article. Review. No abstract available.

5

Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study.

Alikhan R, Cohen AT, Combe S, Samama MM, Desjardins L, Eldor A, Janbon C, Leizorovicz A, Olsson CG, Turpie AG. Alikhan R, et al. Blood Coagul Fibrinolysis. 2003 Jun;14(4):341-6. doi: 10.1097/00001721-200306000-00004. Blood Coagul Fibrinolysis. 2003. PMID: 12945875 Clinical Trial.

6

The safety of antithrombotic therapy during pregnancy.

Ageno W, Crotti S, Turpie AG. Ageno W, et al. Expert Opin Drug Saf. 2004 Mar;3(2):113-8. doi: 10.1517/eods.3.2.113.27343. Expert Opin Drug Saf. 2004. PMID: 15006717 Review.

7

Thromboprophylaxis in medical patients: the role of low-molecular-weight heparin.

Turpie AG, Norris TM. Turpie AG, et al. Thromb Haemost. 2004 Jul;92(1):3-12. doi: 10.1160/TH03-07-0469. Thromb Haemost. 2004. PMID: 15213839 Review.

8

Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients.

Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Vaitkus PT, Goldhaber SZ; PREVENT Medical Thromboprophylaxis Study Group. Leizorovicz A, et al. Circulation. 2004 Aug 17;110(7):874-9. doi: 10.1161/01.CIR.0000138928.83266.24. Epub 2004 Aug 2. Circulation. 2004. PMID: 15289368 Clinical Trial.

9

Prevention of venous thromboembolism among hospitalized medical patients.

Goldhaber SZ, Turpie AG. Goldhaber SZ, et al. Circulation. 2005 Jan 4;111(1):e1-3. doi: 10.1161/01.CIR.0000150393.51958.54. Circulation. 2005. PMID: 15630031 Review. No abstract available.

10

Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients.

Vaitkus PT, Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Goldhaber SZ; PREVENT Medical Thromboprophylaxis Study Group. Vaitkus PT, et al. Thromb Haemost. 2005 Jan;93(1):76-9. doi: 10.1160/TH04-05-0323. Thromb Haemost. 2005. PMID: 15630494

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

229 results

Search Page

Filters